Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > Voices > Delivering cancer care during the pandemic in Europe’s most overstretched health system
  • Voices

Delivering cancer care during the pandemic in Europe’s most overstretched health system

  • 10 May 2020
  • Geta Roman
Geta Roman is a Bucharest-based freelance journalist writing about history and medicine. For more than 10 years she was a health editor for Romanian newspapers Cotidianul and Evenimentul Zilei
Delivering cancer care during the pandemic in Europe’s most overstretched health system
Total
0
Shares
0
0
0
0
0

In a 2016 Voices post, Geta Roman wrote about the daily struggle to deliver timely and high-quality diagnostics and care in a health system with a per capita healthcare expenditure of only €400 a year ‒ the lowest of any European country.

With the coronavirus crisis now testing the resilience of even the best resourced healthcare systems, she asked cancer professionals and advocates how services for Romania’s 120,000 cancer patients are being affected.

Safety first

Strong measures are in place to safeguard staff and patients from exposure to the coronavirus, at least in the main cancer centres in Bucharest, Cluj and Iasi, according to one cancer nurse who works at Bucharest’s Prof. Dr. Alexandru Trestioreanu Institute for Oncology.
Staff work with personal protective equipment “a special mask, protection for the eyes and gloves,” and they work in shifts, she says. This is partly to reduce the number of staff on site at any one time, to make it easier to maintain social distancing, and partly because staff numbers are markedly down, as people with potential COVID symptoms self-isolate to minimise the chances of spreading the infection.

While the system works well, she says, “Our activity is clearly less than before.”
To further reduce the risks of infection, visitors are no longer permitted and patients are not allowed to bring anyone to accompany them when they attend consultations or treatment sessions.

New rules posted in red type on the home page of Bucharest’s main cancer centre inform users that “Access is prohibited to visitors and caregivers…Patients who can travel on their own are asked to come alone, and patients who cannot come on their own may be accompanied by a single friend or relative”

Surgeries and CT-scans are postponed

In general, it seems that patients who are already on treatment are still following the protocol for their chemotherapy. However, while surgery for some cancer patients is continuing, it is less than before. Many non-emergency surgeries have been delayed, and a new protocol requires that all cancer patients who need surgery must be isolated and tested for COVID 19, twice, before the operation.

Cezar Irimia, President of the Federation of Cancer Associations of Romania, says the delays are a matter of concern. “From my point of view there is a big problem because a lot of surgeries are postponed. Patients are following the chemo treatments, but delaying the surgery, the effect of the treatment will be lost.”

Delays to imaging investigations are another major worry, he says. “We’ve had complaints from patients who received calls telling them their appointments have been postponed or cancelled.” The reason for these cancellations is not clear. “I suspect they are afraid to continue investigations because of the risk of spreading the coronavirus,” says Irimia, who adds that many scheduled appointments at oncology hospitals are also being cancelled or postponed.

While the Federation of Cancer Associations of Romania backs measures to reduce the risk of exposing patients to COVID-19 infection patients, it has stressed the importance of appropriate safety measures that can allow diagnostic and treatments to carry on as far as possible. Irimia says it was the patient groups who insisted that all cancer patients who go for treatment and surgery are tested for COVID-19.

He has been impressed by the way some of the large cancer institutes have responded to the challenge, but he says that, away from the major cities, smaller hospitals are struggling. “The Oncology Institute in Cluj took the lead,” he says. “I must say that they are really well organised. Some older problems we had are still here ‒ we do not have enough oncologists, some basic medication is not available. In smaller cities there are problems ‒ in Onesti, for instance, the local hospital was dedicated to COVID-19, so cancer patients have had to find other places to follow their treatments. There are not enough places for bronchoscopies, and pathology services are limited as well.”

Bringing healthcare delivery into the digital age

The impact of the coronavirus on patient care has not been all bad, however, says one oncologist from Bucharest’s Prof. Dr. Alexandru Trestioreanu Institute for Oncology. One change welcomed by many, she says, is that prescriptions can now be issued online, so patients do not have to visit their oncologist every time. “We reduced the number of patient visits, and they mainly come if they are on treatment. Those who need consultations send us their investigations by email, and in case of progression we call them to come to the hospital. If they are in good shape, we schedule a visit in three to six months… We are organised very well to limit our patients’ movement. We work in an incredibly fast rhythm so that they can spend less time in the hospital when they need to come to us.”

Oncology centres are also working with GPs to deliver care closer to the patients’ home where possible, she says, which many patients may find preferable, particularly at a time when new regulations oblige them to make the journey to consultations unaccompanied by a friend or relative.

Most commentators would agree that greater use of digital communication and a move to deliver more care closer to the patient’s home are important moves in the right direction for Romania’s cancer services. However, the speed of change means that GPs and other local services may lack the training and preparation to take on more of a role in caring for cancer patients, while patients themselves may feel scared and abandoned by the steep reduction in face to face contact with their oncologists. A question for the future is how these changes will play out as Romania’s cancer services emerge from the coronavirus emergency.

Cancer and COVID-19 deaths

So far (April 30th 2020) almost 700 deaths from COVID-19 have been registered in Romania. Almost 10% of them were cancer patients, according to official data provided by the Romanian Centre for Prevention and Control for Transmissible Diseases.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • cancer care
  • CEE
  • covid-19
  • GPs
  • inpatient
  • outpatient
  • Romania
Geta Roman

Previous Article
  • Articles
  • Delivery of Care

MDT meetings: why patient care suffers if I’m not there

  • 10 May 2020
  • Janet Fricker
View Post
Next Article
  • News

The misuse of “noninferiority” in presenting trials is often misleading

  • 11 May 2020
  • Elena Riboldi
View Post
You May Also Like
View Post
  • Voices

Obesity and cancer: 12 things clinicians and patients should know

  • Neli Ulrich
  • 23 September 2022
View Post
  • Voices

GDPR: Why patient control over our health data might not be such a bad thing 

  • Gilly Spurrier
  • 23 June 2022
View Post
  • Voices

Angelita Habr-Gama: putting Brazil on the cancer research leaderboard

  • Valéria Hartt
  • 27 May 2022
View Post
  • Voices

Message from a Ukrainian oncologist: Please prioritise my patients ‒ if you don’t who will?

  • Mohammed Hojouj
  • 19 April 2022
View Post
  • Voices

Crisis in the Ukraine: we can help by doing what we do best

  • Kathy Oliver
  • 4 March 2022
View Post
  • Voices

How we turn lung cancer care into a European success story

  • Joanna Chorostowska-Wynimko
  • 21 January 2022
Liver cancer and Elpa
View Post
  • Voices

Liver patient advocates to Europe’s cancer community: can we talk?

  • Marko Korenjak
  • 10 December 2021
View Post
  • Voices

We need a National Cancer Institute! Why Italy should follow the example of the US and France

  • Silvio Monfardini
  • 11 November 2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
  • AI application in diagnosis
    • 11 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.